GIULIA SIBILLE
Technician
I graduated in Biology and got my Master Degree in Medical Biotechnologies at the University of Turin. I obtained my PhD in Experimental Medicine and Therapy at the University of Turin. I joined LMV in 2019.
My research focuses on the identification and characterization of broad-spectrum antiviral compounds,
which will represent a valuable resource for future treatments of infections caused by several DNA and RNA viruses (e.g. Herpes Simplex Virus).
TEACHING
CONTACTS
+39 0116704523
RESEARCH
antivirals (details)
THREE OF MY BEST RECENT PUBLICATIONS
-
Sibille G., Maggiora A., Cimato G., Luganini A., Gribaudo G. Targeting the human protein disulfide isomerase A3 as a broad-spectrum antiviral approach against human respiratory viruses. Int J Antimicrob Agents 2026, 67(7): 107802. https://doi.org/10.1016/j.ijantimicag.2026.107802.
-
Citarella A., Sibille G., Moi D., Dimasi A., Braga T., Dal Col L., Ruberto L., Pieraccini S., Sironi M., Micale N., Schirmeister T., Fasano V., Silvani A., Giannini C., Gribaudo G., Passarella D. Synthesis and multitarget inhibitory effect of indole- based ethyl cinnamate derivatives against SARS-CoV-2 M pro and cathepsins for broad-spectrum anti-coronavirus activity. Bioorg. Med. Chem. 2025, 128: 118258. https://doi.org/10.1016/j.bmc.2025.118258.
-
Sibille G., Mannino G., Frasson I., Pavan M., Luganini A., Salata C., Maffei M.E., Gribaudo G. The Novel A-Type Proanthocyanidin-Rich Phytocomplex SP4™ Acts as a Broad-Spectrum Antiviral Agent against Human Respiratory Viruses. Int. J. Mol. Sci. 2024, 25 (13): 7370. https://doi.org/10.3390/ijms25137370.